RxDoctor Payments Data

Sanjum Paul Samagh, MD

Orthopaedic Surgery · Encinitas, CANPI 1952716524

Payments from drug & device makers

$44,277in general payments, 2019–2025

Across 272 payments — averaging $162.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$39K
  • Impactortho, Inc.$2K
  • Sportstek Medical, Inc$1K
  • Arthrex$832
  • Smith+Nephew$473
  • Elevate Surgical Co$320
  • plus $223 from 5 others

What the payments were for

  • Consulting fees$24,50055%
  • Travel & lodging$4,1899%
  • Food & beverage$12,10227%
  • Education$3,4868%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker(2 entities)227$38,943
Impactortho, Inc.2$2,400
Sportstek Medical, Inc1$1,086
Arthrex9$832
Smith+Nephew14$473
Elevate Surgical Co9$320
Bioventus LLC4$78
Heron Therapeutics, Inc.2$70
Organogenesis Inc.2$43
Axogen1$16
Integra Lifesciences Corporation1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$44,277 in reported general payments places this provider in the 85th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California

Medicare billing

Part B allowed, 2024
$332,431
Medicare patients
315
Services billed
8,994

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen51$374
Ondansetron Hcl49$175

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Encinitas

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →